Covid And

"The Corona crisis and the Need for a Great Reset" is a guide for anyone who wants to understand how COVID-19 disrupted our social and economic systems, and what changes will be needed to create a more inclusive, resilient and sustainable world going forward. Thierry Malleret, founder of the Monthly Barometer, and Klaus Schwab, founder and executive Chairman of the World Economic Forum, explore what the root causes of these crisis were, and why they lead to a need for a Great Reset.Theirs is a worrying, yet hopeful analysis. COVID-19 has created a great disruptive reset of our global social, economic, and political systems. But the power of human beings lies in being foresighted and having the ingenuity, at least to a certain extent, to take their destiny into their hands and to plan for a better future. This is the purpose of this book: to shake up and to show the deficiencies which were manifest in our global system, even before COVID broke out.

COVID-19 is the most significant global crisis of any of our lifetimes. The numbers have been stupefying, whether of infection and mortality, the scale of public health measures, or the economic consequences of shutdown. Coronavirus Politics identifies key threads in the global comparative discussion that continue to shed light on COVID-19 and shape debates about what it means for scholarship in health and comparative politics. Editors Scott L. Greer, Elizabeth J. King, Elize Massard da Fonseca, and André Peralta-Santos bring together over 30 authors versed in politics and the health issues in order to understand the health policy decisions, the public health interventions, the social policy decisions, their interactions, and the reasons. The book’s coverage is global, with a wide range of key and exemplary countries, and contains a mixture of comparative, thematic, and templated country studies. All go beyond reporting and monitoring to develop explanations that draw on the authors' expertise while engaging in structured conversations across the book.

Over the last two years with the strain of coronavirus having a devastating effect on the world’s healthcare system and triggering a global "lockdown", one question that has emerged; What, or which infectious disease is going to hit us next? Many infectious diseases prevalent in humans and animals are caused by pathogens that once emerged from other animal hosts. In addition to these established or re-emerging infections, new infectious diseases periodically emerge. In extreme cases they may lead to pandemics as we currently are seeing. The increased urbanization and globalization of the world order with faster connectivity and traveling has further in-creased the risk factors for emerging infections. Despite this, enormous progress has been made in the field of infectious disease in the last few decades. The number of deaths and severe infections because of diseases like Malaria, HIV, Ebola, Dengue, Yellow fever virus (YFV), Zika etc. have been significantly reduced and diseases like Polio are on the brink of eradication. In particular, the emergence of the devastating SARS-CoV-2 pandemic has revolutionized the field in an unprecedented way. A myriad of vaccine platforms and highly potent therapeutic approaches have been developed by government, industry, academic, and non-governmental organizations. However, the rapid and unparalleled spread of SARS-CoV-2 and its variants, and the amount of toll that it has caused to the public health and global economy also underscores the urgent need to develop broadly cross-reactive, rapidly deployable, and scalable therapeutic platforms. Development of these novel therapeutic modalities also requires a strong emphasis on the functional and mechanistic understanding of how molecular components in a biological process related to emerging infectious diseases work together. Onset of the out-breaks of recent decades including but not limited to SARS-CoV-1, MERS, Ebola virus, Zika virus, Nipah virus, Yellow fever virus, Lassa virus and the ongoing ever devastating SARS-CoV-2 pandemic also highlight the urgent need to devise a future proof pandemic preparedness strategy and the demand for a fast and early response.

For two years the COVID-19 pandemic has upended the world. The physician and medical historian Jacalyn Duffin presents a global history of the virus, with a focus on Canada. Duffin describes the frightening appearance of the virus and its identification by scientists in China; subsequent outbreaks on cruise ships; the relentless spread to Europe, the Americas, Africa, and elsewhere; and the immediate attempts to confront it. COVID-19 next explores the scientific history of infections generally, and the discovery of coronaviruses in particular. Taking a broad approach, the book explains the advent of tests, treatments, and vaccines, as well as the practical politics behind interventions, including quarantines, barrier technologies, lockdowns, and social and financial supports. In concluding chapters Duffin analyzes the outcome of successive waves of COVID-19 infection around the world: the toll of human suffering, the successes and failures of control measures, vaccine rollouts, and grassroots opposition to governments’ attempts to limit the spread and mitigate social and economic damages. Closing with the fraught search for the origins of COVID-19, Duffin considers the implications of an “infodemic” and provides an cautionary outlook for the future.

Examines how the dynamics emerging from the pandemic affect our most vulnerable populations and shape a new religious landscape The COVID-19 pandemic upset virtually every facet of society and, in many cases, exposed gross inequality and dysfunction. The particular dynamics emerging from the coronavirus pandemic have been felt most intensely by America’s most vulnerable populations, who are disproportionately people of color and the working poor, the people whom the Bible refers to as “the least of these.” This book makes the case that the pandemic was not just a medical phenomenon, or an economic or social one, but also a religious one. Religious practice has been altered in profound ways. Controversies around religious freedom have been re-ignited over debates concerning whether government can restrict church services. Christian white supremacists not only defied shelter in place orders, but found new ways to propagate racist attacks, with their White Christian identity fueling their reactions to the pandemic. Some religious leaders, including those in communities of color, saw the virus as an indicator of God’s wrath, or as a divine test, and viewed altering their traditional practices to mitigate the virus’s spread as a weakening of faith. Religion, Race, and COVID-19 argues that there is a religious hierarchy in US society that puts “the least of these” last while prioritizing those who benefit most from white privilege. Yet these vulnerable populations draw on theological and religious resources to contend with these existential threats. The volume shows how social transformation occurs when faith is both formed and informed during crises, offering compelling insight into the saliency and lasting impact of religiosity within human culture.

Accurate estimation, diagnosis, and prevention of COVID-19 is a global challenge for healthcare organizations. Innovative measures can introduce and implement AI, and Mathematical Modeling applications. This book provides insight into the recent advances of applications, statistical methods, and mathematical modeling for the healthcare industry. This book covers the state-of-the-art applications of AI and Machine Learning in past epidemics, pandemics, and COVID-19. It offers recent global case studies, and discusses how AI and statistical methods, initiatives, and applications such as Machine Learning, Deep Learning, Correlation and Regression Analysis play a major role in the prediction, diagnosis, and prevention of a pandemic. It will also focus on how AI and statistical applications can facilitate and restructure the healthcare system. This book is written for Researchers, Students, Professionals, Executives, and the general public.

Almost nine months since the first recorded case, the novel betacoronovirus; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has now passed 18 million confirmed cases. The multi-disciplinary work of researchers worldwide has provided a far deeper understanding of COVID-19 pathogenesis, clinical treatment and outcomes, lethality, disease-spread dynamics, period of infectivity, containment interventions, as well as providing a wealth of relevant epidemiological data. With 27 vaccines currently undergoing human trials, and countries worldwide continuing to battle case numbers, or prepare for resurgences, the need for efficient, high-quality pipelines for peer-reviewed research remains as crucial as ever.